Skip to Main Content
1440_405-1116_628-768_432

Medicare ACO

ACO Name and Location

St Joseph Regional Health Partners ACO
2801 Franciscan Dr, Bryan, TX 77802

ACO Primary Contact

Primary Contact Name                    Kia Parsi, MD, CMO

Primary Contact Phone Number      979-776-2538

Primary Contact Email Address         [email protected]

Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

Julie Lim

N

Kuppusamy Ragupathi, MD

N

Bcs Abundant Life Family Practice

N

Remon Fino, MD, PA

N

Steve Opersteny

N

Owens Interventional Pain Management PLLC

N

St. Joseph Regional Health Center

Y

Mark B. Lindsay, MD

N

Bryan Radiology Associates

N

James M. Kirby and Joseph J. Fedorchik

N

Central Texas Heart Center

N

Paul Roquet, MD, PA

N

Brazos Lung Associates, LLP

N

Central Texas Digestive Disease Association PA  

N

Charles K. Peirce, MD, PA

N

Stephen L. Hand, OD, PA

N

Kelly W. Lobb, MD, PA

N

Ricardo S. Lemos, MD, PA

N

ACO governing body:

Last Name First Name Member Title/Position Member's Voting Power (Expressed as a percentage or number) Membership Type ACO Participant Legal Business Name and D/B/A, if applicable
Parsi Kia MD, Chair 1 Participant Representative St. Joseph Regioanl Health Center
Steins Michael MD, Voting Member 1 Participant Representative St. Joseph Regioanl Health Center
White Brad MD, Voting Member 1 Participant Representative St. Joseph Regioanl Health Center
Ficklen David MD, Voting Member 1 Participant Representative St. Joseph Regioanl Health Center
Damien David MD, Voting Member 1 Participant Representative St. Joseph Regioanl Health Center
Cheng Clint MD, Voting Member 1 Participant Representative St. Joseph Regioanl Health Center
Colato Fernando MD, Voting Member 1 Participant Representative St. Joseph Regioanl Health Center
Wear Amy MD, Voting Member 1 Community Stakeholder Representative N/A

Key ACO Clinical and Administrative Leadership:

  • ACO Executive: Kia Parsi
  • Medical Director: Kia Parsi
  • Compliance Officer: Christi Knox
  • Quality Assurance/Improvement Officer: Corryne Wicks

Associated committees and committee leadership:

 

 Committee Name

 Committee Leader Name and Position

 Patient and Family Advisory Council 

 Gail Lazarine, Director of Patient Experience

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Critical Access Hospital (CAH) billing under Method II
  • Hospital employing ACO professionals
  • Networks of individual practices of ACO professionals
  • Rural Health Clinic (RHC)

Shared Savings and Losses

Amount of Shared Savings/Losses

  • 3rdAgreement Period
    • Performance Year 2020, $1,613,185
  • Second Agreement Period
    • Performance Year 2019, $0
    • Performance Year 2018, $0
    • Performance Year 2017, $0
  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution:

  • Third Agreement Period
    • Performance Year 2020
      • Proportion allocated to confirmed PY FTE infrastructure expenditures: 34% for 2020 (percentage variable due to fixed cost allocation)
      • Proportion held for Reserves for Potential Downside Payment: 40%
      • Proportion of distribution to ACO participants: 26%

Quality Performance Results

2020 Quality Performance Results:

ACO #

Measure Name

Rate

ACO Mean

ACO-43

Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91)

0.78

0.95

ACO-13

Falls: Screening for Future Fall Risk

85.77

84.97

ACO-14

Preventive Care and Screening: Influenza Immunization

67.72

76.03

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

41.18

81.67

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

72.76

71.46

ACO-19

Colorectal Cancer Screening

76.26

71.58

ACO-20

Breast Cancer Screening

72.53

74.05

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

83.68

82.17

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

12.65

14.70

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

72.22

72.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS® for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For Previous Year's Financial and Quality Performance Results, Please Visit data.cms.gov.  

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.

Learn the Stroke Facts